Pancreatic Cancer Cure Foundation to Present Donation to Fund Research at Fox Chase Cancer Center

Dr. Cukierman (third from right) presented with donation of $28,500 for her lab's research on pancreatic cancer by the Pancreatic Cancer Cure Foundation
Dr. Cukierman (third from right) presented with donation of $28,500 for her lab's research on pancreatic cancer by the Pancreatic Cancer Cure Foundation

PHILADELPHIA (October 15, 2021)—The Pancreatic Cancer Cure Foundation will present a donation of $28,500 to the lab of Edna “Eti” Cukierman, PhD, a co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, on Monday, October 18, to fund further research into detecting and treating pancreatic cancer.

The institute conducts research designed to lead to breakthroughs in the early detection and treatment of pancreatic cancer through the use of innovative clinical trials and drug testing. Researchers at the institute work collaboratively to develop new methods to stop the spread of pancreatic cancer in patients.

The main focus of the Pancreatic Cancer Cure Foundation is to raise funds for institutions dedicated to the research and treatment of pancreatic cancer. The foundation also seeks to raise awareness of the disease, be an advocate for patients facing pancreatic cancer, and emphasize the importance of pancreatic research programs and initiatives.

The check presentation will take place at 1 p.m. on Monday, October 18, at the institute, which is located on the fourth floor of the West Building on Fox Chase’s main campus at 333 Cottman Avenue in Philadelphia.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text